You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
明德生物(002932.SZ):AI技術已應用於博音聽力已商業化的相關產品,目前處於國內領先地位
格隆匯 08-28 10:21

格隆匯8月28日丨有投資者嚮明德生物(002932.SZ)提問,“貴公司投資的“博音聽力”,宣稱是一家專注發展“AI智能助聽器+聽力專家中心”的集設計研發、生產銷售於一體的國家高新技術企業。截止2022年10月,博音聽力已獲國家專利11項,軟件著作權22項。請問博音聽力的AI智能助聽器是否已有成熟技術和產品,是真AI還是玩概念,請正面回答”

明德生物回覆稱,2023年8月,公司旗下明熙創投管理的基金對外投資博音聽力設備(蘇州)有限公司,博音聽力系一傢俱有多年研發積累、廣泛渠道資源、較深團隊資歷的國產助聽器廠家。其擬通過線下傳統渠道、大型商超、殘聯補貼項目、線上(中美市場)等方式多渠道多體系銷售助聽器產品,有機會成為國產醫療級助聽器領先企業。截至目前,AI技術已應用於博音聽力已商業化的相關產品,目前處於國內領先地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account